A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee

PHASE2RecruitingINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

February 26, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2032

Conditions
Osteoarthritis (OA) of the Knee
Interventions
BIOLOGICAL

Enekinragene Inzadenovec (PCRX-201)

Enekinragene Inzadenovec (PCRX-201) injection

BIOLOGICAL

Placebo

Placebo injection

Trial Locations (17)

16635

RECRUITING

Altoona Center for Clinical Research, Duncansville

29206

RECRUITING

Clinical Trials of South Carolina - Columbia, Columbia

29406

RECRUITING

Clinical Trials of South Carolina - Charleston, Charleston

32117

RECRUITING

Arrow Clinical Trials, Daytona Beach

32789

RECRUITING

Conquest Research, Winter Park

33409

RECRUITING

Palm Beach Research Center, West Palm Beach

68516

RECRUITING

Physicians Research Collaboration, Lincoln

75057

RECRUITING

Epic Clinical Research, Lewisville

75230

RECRUITING

Zenos Clinical Research, Dallas

83713

NOT_YET_RECRUITING

Injury Care Research, LLC, Boise

89109

RECRUITING

Excel Clinical Research, Las Vegas

90211

NOT_YET_RECRUITING

Osteoporosis Medical Center, Beverly Hills

91307

RECRUITING

Alliance Clinical West Hills (Focus Clinical Research), West Hills

91942

RECRUITING

Horizon Clinical Research, La Mesa

92647

RECRUITING

Beach Physicians Medical Group Inc., Huntington Beach

34677-4681

RECRUITING

Journey Research Inc., Oldsmar

11235-3919

NOT_YET_RECRUITING

NY Scientific, Brooklyn

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY